Oxcarbazepine for trigeminal neuralgia may induce lower extremity weakness: A case report

Table 1 Clinical characteristics of the patient

Characteristics	Ten months before OXC discontinuation	Unsteady gait OXC discontinuation	After 2 wk	After 4 wk	After 5 wk
VAS	5	5	10	5	4
OXC (mg)	600	600
Topiramate (mg)				75	100
Na (mmol/L)	142	127	134	143
Gait		Several events of fall; the patient required both hand canes and his son’s help to walk	No event of fall; the patient walked alone using both hand canes	The patient walked alone using only one hand cane	Self-ambulation

Na: Sodium; OXC: Oxcarbazepine; VAS: Visual analogue scale.